FIELD: medicine.
SUBSTANCE: claimed invention relates to field of medications, in particular to combination, product, set and packing, intended for treatment of asthma, acute or chronic bronchitis, emphysema, chronic obstructive pulmonary disease (COPD), hyperreactivity of bronchi or rhinitis, containing efficient amount of (a) β2-agonist and efficient amount (b) of antagonist of muscarine receptors M3, which represents (3R)-1-phenethyl-3-(9H-xanten-9-carbonyloxy)-1-azoniumbicyclo[2.2.2]octane in form of salt with anion X, which represents pharmaceutically acceptable anion of mono- or poly-valence acid. Invention also relates to application and treatment methods.
EFFECT: ensuring reduced duration of impact on heart rate.
21 cl, 5 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS, CONNECTING ANTI-MUSCARINIC PREPARATIONS AND BETA-ADRENERTIC AGONISTS | 2010 |
|
RU2465902C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385156C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND INHIBITORS PDE4 | 2005 |
|
RU2404772C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2404771C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385721C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS | 2005 |
|
RU2373935C2 |
| NOVEL ESTERS OF QUATERNISED QUINUCLIDINE | 2005 |
|
RU2382041C2 |
| DERIVATIVES OF QUINUCLIDINEAMIDE, METHOD FOR THEIR PREPARING AND THEIR USING, PHARMACEUTICAL COMPOSITION, COMBINED PRODUCT AND METHOD FOR INHIBITION OF MUSCARINIC RECEPTORS | 2003 |
|
RU2314306C2 |
| NOVEL METHODS | 2008 |
|
RU2484821C2 |
| NEW DOSE AND FORMULATION | 2009 |
|
RU2608713C2 |
